We also observed that the performance of RNF180 and SFRP2 combined with traditional tumor markers to predict GC (AUC=0.858) was slightly better than that of the combination of the RNF180 and SFRP2 alone (AUC=0.844). This evidence concerns the gene SFRP2 and neoplasm.